메뉴 건너뛰기




Volumn 147, Issue 3, 2002, Pages 433-441

Naevi in allogeneic bone marrow transplantation recipients: The effect of graft-versus-host disease on naevi

Author keywords

Bone marrow transplant; Conditioning regimen; Melanocytic naevus; Melanoma; Risk factor

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE;

EID: 0036042554     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04748.x     Document Type: Article
Times cited : (20)

References (27)
  • 5
    • 0030864514 scopus 로고    scopus 로고
    • Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients
    • (1997) Blood , vol.90 , pp. 2826-2829
    • Parravicini, C.1    Olsen, S.J.2    Capra, M.3
  • 14
    • 0031053388 scopus 로고    scopus 로고
    • Health and functional status of long-term survivors of bone marrow transplantation
    • EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation
    • (1997) Ann Intern Med , vol.126 , pp. 184-192
    • Duell, T.1    Van Lint, M.T.2    Ljungman, P.3
  • 15
    • 0025327901 scopus 로고
    • Count of benign melanocytic naevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma
    • (1990) Cancer , vol.66 , pp. 387-395
    • Grob, J.J.1    Gouvernet, J.2    Aymar, D.3
  • 25
    • 0019351639 scopus 로고
    • Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression
    • (1981) Blood , vol.57 , pp. 267-276
    • Sullivan, K.M.1    Shulman, H.M.2    Storb, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.